ENTERO HEALTHCARE SOLUTIONS LIMITED Financials Entero Healthcare Solutions Limited
Equities
ENTERO
INE010601016
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,054 INR | +1.02% |
|
+0.71% | 0.00% |
Valuation
| Fiscal Period: March | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 45,864 | - | - |
| Enterprise Value (EV) 1 | 40,800 | 43,221 | 46,532 |
| P/E ratio | 232 x | 38.8 x | 21.3 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.17 x | 0.85 x | 0.59 x |
| EV / Revenue | 1.04 x | 0.8 x | 0.6 x |
| EV / EBITDA | 35.7 x | 21.9 x | 13.7 x |
| EV / FCF | 554 x | -22.3 x | -18.6 x |
| FCF Yield | 0.18% | -4.49% | -5.36% |
| Price to Book | 2.95 x | 2.76 x | 2.44 x |
| Nbr of stocks (in thousands) | 43,494 | - | - |
| Reference price 2 | 1,054 | 1,054 | 1,054 |
| Announcement Date | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 39,092 | 54,220 | 77,098 |
| EBITDA 1 | - | 1,143 | 1,978 | 3,391 |
| EBIT 1 | - | 915 | 1,467 | 2,536 |
| Operating Margin | - | 2.34% | 2.71% | 3.29% |
| Earnings before Tax (EBT) 1 | - | 260.7 | 1,540 | 2,875 |
| Net income 1 | -115.6 | 197.5 | 1,182 | 2,150 |
| Net margin | - | 0.51% | 2.18% | 2.79% |
| EPS 2 | -0.1800 | 4.553 | 27.19 | 49.44 |
| Free Cash Flow 1 | - | 73.67 | -1,941 | -2,496 |
| FCF margin | - | 0.19% | -3.58% | -3.24% |
| FCF Conversion (EBITDA) | - | 6.45% | - | - |
| FCF Conversion (Net income) | - | 37.31% | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 8/3/23 | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | 668 |
| Net Cash position 1 | - | 5,064 | 2,643 | - |
| Leverage (Debt/EBITDA) | - | - | - | 0.197 x |
| Free Cash Flow 1 | - | 73.7 | -1,941 | -2,496 |
| ROE (net income / shareholders' equity) | - | 2.6% | 7.37% | 11.8% |
| ROA (Net income/ Total Assets) | - | 1.6% | 5.3% | 9.9% |
| Assets 1 | - | 12,342 | 22,309 | 21,716 |
| Book Value Per Share 2 | - | 358.0 | 382.0 | 431.0 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 223 | 1,867 | 2,606 |
| Capex / Sales | - | 0.57% | 3.44% | 3.38% |
| Announcement Date | 8/3/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,054
INR
Average target price
1,511
INR
Spread / Average Target
+43.29%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 551M | |
| +8.79% | 33.98B | |
| +21.06% | 8.16B | |
| +31.70% | 4.26B | |
| -18.04% | 1.4B | |
| -28.50% | 1.27B | |
| -33.58% | 1.17B | |
| +12.29% | 1.02B | |
| -33.89% | 917M | |
| -21.97% | 660M |
- Stock Market
- Equities
- ENTERO Stock
- Financials Entero Healthcare Solutions Limited
